Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Artios Pharma Ltd.

www.artiospharma.com

Latest From Artios Pharma Ltd.

New UK Life Sciences VC Fund Aims To Tap CRUK R&D And Accelerate Drug Development

Cancer Research UK has formed a partnership with SV Health Investors aimed at funding innovative science created from CRUK’s research network.

Deals Strategy

Biotech CEOs: Can Scientist-Founders Remain In Charge?

Founder-CEOs do not typically remain at the helm as biotechs mature. Exceptions to that rule are multiplying, though, especially in Europe as companies aim directly for Nasdaq.

C-Suite Speaks Business Strategies

Incubator Addition: Arix CIO On Why Fund Added VelosBio To Portfolio

Incubator fund Arix Bioscience has expanded its start-up portfolio to 15 by co-leading a series A financing for - and taking an equity stake in – antibody-drug conjugate specialist VelosBio. CIO Joe Anderson explains why.

Business Strategies Commercial

Assessing Artios: $83m Series B, Big-Name Investors, Nothing In The Clinic

Cambridge, UK-based Artios Pharma attracted several new investors for its over-subscribed series B round in August 2018, but the company is yet to enter the clinic with its DNA repair drug portfolio and has many hurdles ahead to validate its technology. Scrip speaks to investors from LSP and Arix about why preclinical-stage biotechs are getting more attention in 2018.

Companies Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Artios Pharma Ltd.
  • Senior Management
  • Niall Martin, PhD, CEO
    Andrew Muncey, CFO
    Graeme Smith, PhD, CSO
    Nick Staples, PhD, CBO
    Ian Smith, MD, CMO
  • Contact Info
  • Artios Pharma Ltd.
    Phone: 1223 804180
    c/o The Babraham Institute
    Meditrina B260
    Babraham, CB22 3AT
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register